🔍

BHAGERIA - Bhageria Indust.

📊 NSE: BHAGERIA 🏢 Dyes And Pigments 📅 Last Updated: 12/13/2025 19:24

📢 Recent Corporate Announcements

Bhageria Industries Declares ₹2.50 Dividend, Approves FY26 Results & Appoints New Auditors

🟢 POSITIVE ⭐ 7/10

BOARD_MEETING 📅 02 May 2026, 01:54 PM

Bhageria Industries' board approved the audited financial results for the quarter and year ended March 31, 2026. The company recommended a dividend of ₹2.50 per equity share, which is 50% of the ₹5 face value. To enhance internal controls, the board appointed M/s Kamal Dhanuka & Co as Internal Auditors and M/s K V M & Co as Cost Auditors for a one-year term. These appointments follow the company's commitment to robust risk management and compliance across its diverse business sectors.

Recommended a dividend of ₹2.50 per share (50% of face value) for the financial year 2025-26.
Approved audited standalone and consolidated financial results for the period ending March 31, 2026.
Appointed Mr. Kamal Dhanuka, a professional with 35+ years of experience, as the Internal Auditor.
Appointed M/s K V M & Co as Cost Auditors for chemical manufacturing and solar power operations.

💡 Investors should view the dividend and auditor appointments as signs of stable governance and cash flow. Monitor the upcoming AGM for the final dividend approval and detailed segment-wise performance.

Bhageria Industries Defers Shifting of Registered Office Effective April 1, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 01 Apr 2026, 10:47 AM

Bhageria Industries Limited has announced the deferment of its registered office relocation, which was originally scheduled to take effect on April 1, 2026. The company cited administrative and operational exigencies for this delay, following a previous board approval dated February 2, 2026. The shifting process is now on hold until further notice, and the company will provide a revised date once finalized. This is a procedural update and does not impact the company's core business operations or financial health.

Relocation of the registered office originally planned for April 1, 2026, has been deferred.
The move was previously approved by the Board of Directors on February 2, 2026.
Delay is attributed to administrative and operational exigencies.
The company will intimate stock exchanges regarding the revised effective date in the future.

💡 This is a routine administrative matter with no impact on the company's fundamentals. Investors should ignore this update and focus on the company's quarterly performance and sector trends.

Bhageria Industries Receives GST Demand and Penalty Totaling Over ₹2.1 Crore

🔴 NEGATIVE ⭐ 4/10

LEGAL 📅 31 Mar 2026, 11:58 AM

Bhageria Industries has been served a GST demand order from the Office of the Asst./ Dy. Commissioner of (CGST & Central Excise), Palghar. The order confirms a demand of ₹1.05 crore for ineligible Input Tax Credit (ITC) for the period April 2019 to March 2020. Additionally, a penalty of ₹1.05 crore has been imposed along with applicable interest under Section 50 of the CGST Act. The company has stated it will file an appeal before the Commissioner (Appeals) to contest this order.

Demand of ₹1,05,22,565 in IGST confirmed due to ineligible Input Tax Credit.
Penalty of ₹1,05,22,565 imposed, equivalent to 100% of the tax demand.
Order pertains to the financial year 2019-20 under Section 74(9) of the CGST Act.
Company intends to file an appeal before the Commissioner (Appeals) within the due date.
Total potential financial liability exceeds ₹2.1 crore excluding interest.

💡 Investors should monitor the outcome of the appeal process as any unfavorable final ruling will impact the company's profitability. The current impact is limited to a potential contingent liability while the legal process continues.

Bhageria Industries Commissions 7 MW Solar Power Plant in Maharashtra

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 28 Mar 2026, 02:51 PM

Bhageria Industries' wholly-owned subsidiary, Rahuri Cleantech Private Limited, has successfully commissioned a 7 MW Solar PV Power Plant in Maharashtra. This project is part of a larger 32 MW aggregate capacity under the Mukhyamantri Saur Krushi Vahini Yojana (MSKVY) 2.0 scheme. The plant, located at Bhatkudgaon, consists of two bays of 3.5 MW each and is now fully operational. This commissioning strengthens the company's renewable energy portfolio and is expected to contribute positively to its long-term revenue and sustainability goals.

Successfully commissioned 7 MW Solar PV Power Plant through subsidiary Rahuri Cleantech Private Limited.
The project is part of an aggregate 32 MW capacity under the MSKVY 2.0 scheme.
The 7 MW capacity is divided into two bays of 3.5 MW each at Bhatkudgaon, Maharashtra.
The plant became operational on March 27, 2026, enhancing the company's green energy footprint.

💡 Investors should view this as a positive development in the company's diversification into renewable energy. Monitor the execution and commissioning of the remaining 25 MW capacity under the MSKVY 2.0 scheme for further growth triggers.

Bhageria Industries Announces Trading Window Closure from April 1, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 23 Mar 2026, 02:43 PM

Bhageria Industries Limited has announced the closure of its trading window for all designated persons starting April 1, 2026. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the upcoming financial results. The window will remain closed until 48 hours after the declaration of the audited financial results for the quarter and year ending March 31, 2026. The specific date for the board meeting to approve these results will be notified at a later date.

Trading window for designated persons to close effective Wednesday, April 1, 2026.
Closure is related to the finalization of Audited Financial Results for the quarter and year ending March 31, 2026.
Trading restriction will be lifted 48 hours after the official results are declared.
The board meeting date for result consideration is yet to be announced.

💡 This is a routine regulatory filing with no direct impact on stock fundamentals; investors should monitor for the upcoming board meeting date to review annual performance.

Bhageria Industries to Restart Tarapur H-Acid Unit Following MPCB Approval

🟢 POSITIVE ⭐ 6/10

REGULATORY 📅 19 Mar 2026, 12:23 PM

Bhageria Industries has received conditional approval from the Maharashtra Pollution Control Board (MPCB) to restart its H-Acid manufacturing unit at Tarapur. The unit had been shut down since March 2, 2026, following a voluntary closure direction related to environmental compliance. As part of the restart order, the company faced a ₹1,00,000 bank guarantee forfeiture for previous non-compliance. Operations are now permitted to resume subject to strict adherence to safety and environmental protocols.

Conditional restart directions issued for the Sulphonation section of the H-Acid unit at Tarapur
Resumption follows a closure period initiated on March 02, 2026
Penalty of ₹1,00,000 imposed via bank guarantee forfeiture due to non-compliance
Mandatory adherence to safety directives regarding oleum handling in the H-Acid plant

💡 The restart of the Tarapur unit is a positive step towards restoring full production capacity and revenue flow. Investors should monitor the company's ability to maintain environmental standards to avoid future regulatory disruptions.

Bhageria Industries: SAT Adjourns SEBI Order Appeal to May 2026; Stay Continues

🔵 WATCH ⭐ 6/10

LEGAL 📅 12 Mar 2026, 05:11 PM

Bhageria Industries has informed that the Securities Appellate Tribunal (SAT) has adjourned the hearing regarding an appeal against a SEBI adjudication order dated March 31, 2023. The matter, which involves the company's promoters and directors, was originally scheduled for March 12, 2026, but is now rescheduled for final disposal between May 5 and May 7, 2026. Crucially, the SAT has extended the stay on the original SEBI order until the next hearing dates. This delay maintains the status quo for the management and promoters involved in the litigation without immediate regulatory penalties.

SAT adjourned the hearing from March 12, 2026, to the new dates of May 5-7, 2026.
The appeal challenges a SEBI adjudication order originally passed on March 31, 2023.
The stay on the SEBI order remains in effect until the final disposal in May 2026.
The litigation involves the company's Promoters, Promoter Group, and Directors.
Final disposal of the matter is expected during the May 2026 hearing window.

💡 Investors should monitor the final verdict in May 2026 as it involves promoter-level regulatory issues. While the stay is a temporary relief, the nature of the SEBI adjudication could impact corporate governance perception.

Bhageria Industries' ₹91 Cr Bank Facilities Placed on Rating Watch with Negative Implications

🔴 NEGATIVE ⭐ 7/10

REGULATORY 📅 12 Mar 2026, 02:42 PM

CARE Ratings has placed Bhageria Industries' bank facilities totaling ₹91.00 crore on 'Rating Watch with Negative Implications' (RWN). This action is primarily driven by a voluntary closure notice from the Maharashtra Pollution Control Board (MPCB) for the company's sulphonication plant in Palghar. The rating agency is also assessing the impact of the company's 9M FY26 financial performance on its credit profile. This status indicates a potential downgrade if regulatory issues persist or financial metrics deteriorate further.

CARE Ratings placed ₹91.00 crore of long-term and short-term bank facilities on Rating Watch with Negative Implications.
The rating action follows a voluntary closure notice issued by the MPCB for the Palghar sulphonication plant.
The review also considers the company's operational and financial performance for the 9M FY26 period.
Previous ratings were CARE A (Stable) for long-term and CARE A1 for short-term facilities.
The rating agency will finalize its view once the exact implications of the plant closure on the credit profile are clear.

💡 Investors should monitor the duration of the plant closure and its impact on the company's production and revenue. The 'Negative Watch' suggests a heightened risk of a credit downgrade, which could increase future borrowing costs.

Bhageria Industries Faces Temporary Closure of Tarapur Unit Section After Oleum Leakage

🔴 NEGATIVE ⭐ 6/10

REGULATORY 📅 03 Mar 2026, 04:52 PM

Bhageria Industries has received a voluntary closure direction from the Maharashtra Pollution Control Board (MPCB) for the Sulphonation section of its H Acid unit in Tarapur. The order follows an incident where an Oleum measuring tank fell, causing a localized fume leakage, though no casualties were reported. While the company states there is no material financial impact, operations at this specific section are temporarily halted pending a safety audit. Investors should monitor the timeline for the resumption of operations and any potential impact on production volumes.

MPCB issued closure directions for the Sulphonation section of the H Acid unit at Plot No. D-17, Tarapur.
The incident involved the fall of an Oleum measuring tank leading to fume leakage; no injuries were reported.
Company must conduct a safety audit and obtain approvals from MPCB and DISH before restarting operations.
Management stated there is no material financial impact expected from this temporary disruption.

💡 Investors should watch for updates regarding the safety audit and the timeline for restarting the affected section. Any prolonged delay in resuming H Acid production could impact the chemicals segment's revenue.

Bhageria Industries Reports Operational Disruption at Tarapur Plant Due to Oleum Leakage

🔴 NEGATIVE ⭐ 6/10

OTHER 📅 03 Mar 2026, 02:04 PM

Bhageria Industries Limited reported an operational incident on March 2, 2026, at its manufacturing facility in MIDC Tarapur, Maharashtra. The incident involved the fall of a measuring tank containing Oleum, which led to a leakage of fumes and a temporary fog-like situation in the area. While the company confirmed there were no casualties or injuries, operations at the site have been temporarily disrupted. Management is currently assessing the extent of the impact on production and assets.

Incident occurred on March 2, 2026, at the Plot No. D-17, MIDC Tarapur manufacturing plant.
A measuring tank containing Oleum fell, causing a leakage of fumes and temporary environmental disruption.
Zero casualties or injuries were reported as all personnel were safely evacuated from the site.
Operations at the facility are temporarily halted while the company assesses the total impact.

💡 Investors should monitor for updates regarding the duration of the plant shutdown and any potential regulatory actions from environmental boards. Expect short-term volatility in the stock price until production resumes and the financial impact is quantified.

Bhageria Industries Commissions 7MW Solar Power Plant in Maharashtra

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 26 Feb 2026, 07:00 PM

Bhageria Industries' wholly-owned subsidiary, Rahuri Cleantech Private Limited, has successfully commissioned a 7MW Solar PV Power Plant at Pimpalgaon Wagha, Maharashtra. This 7MW capacity is the first phase of a larger 32MW total project planned under the MSKVY 2.0 scheme. The commissioning was completed on February 25, 2026, and marks a significant step in the company's renewable energy expansion. This development is expected to contribute to the company's green energy revenue stream and long-term sustainability goals.

Commissioned 7MW Solar PV Power Plant at Pimpalgaon Wagha, Ahilyanagar
Project executed through wholly-owned subsidiary Rahuri Cleantech Private Limited
Represents the first phase of a total 32MW capacity under the MSKVY 2.0 scheme
Official commissioning date recorded as February 25, 2026
Strengthens the company's presence in the renewable energy sector

💡 Investors should view this as a positive development for long-term cash flow stability and monitor the execution timeline for the remaining 25MW capacity. The shift towards renewable energy provides a hedge against the cyclical nature of the company's core chemical business.

Bhageria Industries Q3 FY26 Revenue Jumps 45% to ₹244.5 Cr; Net Profit Dips to ₹10.8 Cr

🟡 NEUTRAL ⭐ 8/10

EARNINGS 📅 04 Feb 2026, 12:17 PM

Bhageria Industries reported a significant 45% year-on-year increase in consolidated revenue for Q3 FY26, reaching ₹244.50 crore. Despite the top-line growth, consolidated net profit for the quarter saw a marginal decline to ₹10.84 crore from ₹11.38 crore in the previous year, suggesting margin compression. However, the nine-month performance remains strong, with cumulative net profit rising to ₹33.20 crore compared to ₹23.57 crore in the same period last year. The results reflect robust demand but highlight potential challenges in maintaining profitability levels on a quarterly basis.

Consolidated total income for Q3 FY26 rose to ₹244.50 crore from ₹168.39 crore in Q3 FY25.
Consolidated net profit for the quarter stood at ₹10.84 crore, down approximately 4.7% from ₹11.38 crore YoY.
Nine-month consolidated revenue grew substantially to ₹614.49 crore from ₹417.98 crore in the previous year.
Consolidated Earnings Per Share (EPS) for the quarter was ₹2.56, compared to ₹2.78 in the year-ago period.
Standalone revenue for Q3 FY26 was ₹245.35 crore with a net profit of ₹12.02 crore.

💡 Investors should investigate the cause of the margin contraction despite the strong revenue growth. While the nine-month trajectory is positive, the quarterly profit dip suggests a need to monitor rising input costs or operational expenses.

Bhageria Industries Q3 Revenue Jumps 45% YoY to ₹244.5 Cr; Net Profit Dips to ₹10.8 Cr

🟡 NEUTRAL ⭐ 7/10

EARNINGS 📅 04 Feb 2026, 12:14 PM

Bhageria Industries reported a robust 45.2% year-on-year growth in consolidated revenue for Q3 FY26, reaching ₹244.50 crore. Despite the top-line surge, consolidated net profit declined slightly to ₹10.84 crore from ₹11.38 crore in the same quarter last year. Sequentially, revenue grew by 18.7%, but net profit fell from ₹11.47 crore in Q2 FY26. The results indicate strong demand but suggest rising operational costs or margin compression as EPS fell to ₹2.56.

Consolidated Total Income rose 45.2% YoY to ₹24,450.29 Lakhs from ₹16,838.62 Lakhs.
Consolidated Net Profit for the quarter stood at ₹1,083.98 Lakhs, a decline from ₹1,137.54 Lakhs YoY.
9M FY26 consolidated revenue showed a significant jump to ₹61,448.87 Lakhs compared to ₹41,797.89 Lakhs in 9M FY25.
Earnings Per Share (EPS) for Q3 FY26 decreased to ₹2.56 from ₹2.78 in the corresponding previous year quarter.
Standalone Net Profit for the quarter was higher than consolidated at ₹1,202.07 Lakhs.

💡 While the revenue growth is impressive, the decline in net profit despite higher sales warrants caution regarding margin sustainability. Investors should monitor if the company can pass on rising costs to maintain profitability in future quarters.

Bhageria Industries Q3 Revenue Jumps 41% YoY to ₹242 Cr; Plans New Mineral Subsidiary

🔵 WATCH ⭐ 7/10

EARNINGS 📅 02 Feb 2026, 07:19 PM

Bhageria Industries reported a robust 41% YoY growth in revenue for Q3 FY26, reaching ₹241.92 crore. Despite the top-line surge, net profit for the quarter declined by 7% YoY to ₹12.02 crore, reflecting margin pressure from increased raw material and stock-in-trade costs. On a nine-month basis, the performance remains strong with PAT up 40.5% to ₹36.20 crore. Additionally, the board has approved a strategic diversification into the mineral business via a new wholly-owned subsidiary.

Revenue from operations increased 41% YoY to ₹24,192.57 Lakhs in Q3 FY26.
Net profit for the quarter stood at ₹1,202.07 Lakhs, a slight decline from ₹1,293.69 Lakhs in Q3 FY25.
9-Month PAT grew significantly by 40.5% YoY to ₹3,619.66 Lakhs.
Chemical segment remains the dominant revenue driver, contributing ₹22,958.01 Lakhs during the quarter.
Board approved in-principle the incorporation of a Wholly Owned Subsidiary for the Mineral business.

💡 Investors should monitor the rising cost of materials which impacted quarterly margins despite high revenue growth. The planned entry into the mineral business suggests a diversification strategy that could impact future capital expenditure and long-term growth profiles.

Bhageria Industries to Shift Registered Office to Malad, Mumbai Effective April 1, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 02 Feb 2026, 06:56 PM

Bhageria Industries Limited has announced that its Board of Directors granted in-principle approval on February 2, 2026, to relocate its registered office. The office will move from Goregaon (West) to Malad (West) within the city of Mumbai. This change is scheduled to take effect from April 1, 2026. As the relocation is within local limits, it represents a routine administrative update with no impact on the company's business operations or financial standing.

Board approval received on February 2, 2026, for shifting the registered office address.
Relocation from Goregaon (West), Mumbai to Malad (West), Mumbai.
The new office address will be effective starting April 1, 2026.
The shift remains within the local limits of Mumbai, maintaining the same regulatory jurisdiction.

💡 This is a routine administrative announcement. No action is required from investors as it does not impact the company's fundamentals or financial performance.

View All BHAGERIA Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

The Chemicals segment grew 26.5% YoY to INR 504.31 Cr. The Pharma segment saw explosive growth of 277.7% YoY, reaching INR 8.12 Cr. Solar Power revenue declined 3.7% to INR 27.83 Cr, while 'Others' declined 12.8% to INR 57.23 Cr.

Geographic Revenue Split

Exports contribute a stable and healthy share to total revenue, though the exact percentage split between domestic and international regions is not disclosed in available documents.

Profitability Margins

Gross margins in the pharma regulatory export market are targeted at nearly 200%. Standalone PAT margin improved significantly from 3.96% in FY24 to 7.08% in FY25 due to operational leverage and better realizations in the chemicals segment.

EBITDA Margin

EBITDA margin stood at 15.21% in FY25, a 298 bps improvement from 12.23% in FY24. Core profitability was driven by a 50% increase in EBITDA to INR 90.82 Cr, supported by rising volumes and price stability in dye intermediates.

Capital Expenditure

The company invested significantly in a new pharma plant with advanced instrumentation and labs. Recent incremental capacity expansion is expected to generate INR 50-75 Cr in additional annual revenue once fully operational.

Credit Rating & Borrowing

CARE Ratings reaffirmed the long-term rating at 'CARE A; Stable' and short-term rating at 'CARE A1' for bank facilities totaling INR 91 Cr as of October 2025.

⚙️ Operational Drivers

Raw Materials

Key raw materials include chemicals for dye intermediates and pigments, as well as specific pharmaceutical intermediates like MCP (Monochloroparaffin). Raw materials represent a significant portion of the cost structure, though specific percentage breakdowns per material are not disclosed.

Import Sources

Not specifically disclosed, though the company mentions strengthening supply stability by controlling part of its raw material sourcing and integrating operations in-house.

Capacity Expansion

Current plants are operating at 95% utilization. Planned incremental capacity is expected to add INR 50-75 Cr to annual revenue at current price levels, signaling a shift toward specialty segments.

Raw Material Costs

The company employs a strategy of backward integration and in-house supply operations to mitigate the risk of raw material shortages and price volatility, which historically impacted margins.

Manufacturing Efficiency

High manufacturing efficiency is evidenced by a 95% capacity utilization rate across existing plants, supported by firm demand from the textile and polymer industries.

📈 Strategic Growth

Expected Growth Rate

15-20%

Growth Strategy

Growth will be achieved through a shift toward higher-margin specialty chemicals, expansion of the pharma portfolio into regulatory markets like Japan (where MCP can sell for $4,000/kg), and incremental revenue of INR 50-75 Cr from new capacity.

Products & Services

Dye intermediates, pigments, specialty chemicals, pharmaceutical intermediates (MCP), and solar power generation.

Brand Portfolio

Bhageria Industries (Corporate Brand).

New Products/Services

Expansion into value-added Specialty segments and regulatory-grade pharma molecules like MCP, which are expected to contribute higher margins than traditional dye intermediates.

Market Expansion

Targeting regulatory pharmaceutical markets globally, specifically mentioning Japan as a high-value destination for pharma exports.

🌍 External Factors

Industry Trends

The Indian chemical industry is seeing a structural shift toward compliant, sustainable manufacturers. Bhageria is positioning itself by focusing on process excellence and sustainable practices to capture this 10-12% industry-wide growth trend.

Competitive Landscape

Faces intensified competition and pricing pressures in the merchant market, countered by product innovation and brand identity.

Competitive Moat

The company's moat is built on backward integration, high capacity utilization (95%), and a transition into high-entry-barrier regulatory pharma markets, which are more sustainable than merchant chemical markets.

Macro Economic Sensitivity

The business is sensitive to the performance of the textile and polymer industries, which drive demand for dyes and pigments.

Consumer Behavior

Increased preference for sustainable and reliable manufacturers in the global supply chain is shifting demand toward companies with robust compliance frameworks.

Geopolitical Risks

Global supply chain realignments are currently benefiting the company as international buyers seek reliable, compliant Indian manufacturers as alternatives to other global sources.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to environmental standards and pharmaceutical regulatory requirements for export markets (e.g., Japanese regulatory standards for MCP).

Environmental Compliance

The company integrates sustainable technologies and practices aligned with regulatory standards to mitigate environmental risks.

Legal Contingencies

Management reported no instances of significant fraud or significant changes in internal control over financial reporting during the year ended March 31, 2025.

⚠️ Risk Analysis

Key Uncertainties

Market volatility and interest rate changes pose risks to project costs and funding access. Pricing pressure in the chemicals segment remains a key uncertainty for margin stability.

Geographic Concentration Risk

While expanding globally, the company maintains a strong presence in India; however, the specific percentage of revenue from top regions is not disclosed.